Matsuo S, Takano S, Yamashita J, Ogawa M
Department of Surgery II, Kumamoto University Medical School, Japan.
Anticancer Res. 1992 Sep-Oct;12(5):1575-9.
The combined effects of recombinant human tumor necrosis factor (TNF), interferon-gamma (IFN) and tamoxifen (TAM) on the proliferation of human breast cancer cell lines were investigated. In estrogen receptor positive MCF-7 cells, relatively resistant to TAM or TNF, cytotoxicity significantly increased in combinations of TNF and IFN, and of a cytokine and TAM. The cytotoxicity of TNF increased when cells were pretreated with IFN, but not vice versa. Sequential treatment with IFN following TNF and TAM also exhibited significant antiproliferative effect on both cell lines. The combined or sequential cytokines and TAM treatments are possible modalities to overcome breast cancers unresponsive to endocrine treatment.
研究了重组人肿瘤坏死因子(TNF)、干扰素-γ(IFN)和他莫昔芬(TAM)对人乳腺癌细胞系增殖的联合作用。在对TAM或TNF相对耐药的雌激素受体阳性MCF-7细胞中,TNF与IFN联合以及细胞因子与TAM联合时,细胞毒性显著增加。当细胞用IFN预处理时,TNF的细胞毒性增加,但反之则不然。TNF和TAM后序贯用IFN处理对两种细胞系也表现出显著的抗增殖作用。细胞因子与TAM联合或序贯处理可能是克服对内分泌治疗无反应的乳腺癌的有效方式。